Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 16,700 shares at $52.09 ($870K) on 2019-06-03, disclosed to the SEC on 2019-06-05.
Open-market sale of $870k NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |